Biotech

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all …

Text size Lucira Health is one of seven biotech or health-care-related companies opening for trading Friday. Courtesy of Lucira Biotechnology companies continue their race to the public equity markets. Seven …

How can we know just where the markets are heading? The new year started with an upward trend that nearly got derailed by a flashmob from Reddit – and suddenly …

The Associated PressFeb 01, 2021 15:25:05 IST While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe. Some use tried-and-true …

Investing in biotech can be a bit of an experiment: I have profiled several small-cap biotech stocks that have grown into real monsters, and others that have gone dormant. The …

As part of the globalization of the India-developed COVID-19 vaccine, India’s Bharat Biotech has applied for “Emergency use authorization” (EUA) in the Philippines. EUA was filed earlier this month in …

InvestorPlace 7 Tech Stocks That Could Be the Future FAANG A few months ago, I began prodding around the idea of, “What are the future FAANG stocks?” We’ve seen Apple …

Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market strength. Eli Lilly And Co (NYSE: LLY) …

India’s Bharat Biotech submitted on Thursday an application for the emergency use of its COVID-19 vaccines in the Philippines, Food and Drug Administration chief Rolando Enrique Domingo said. If allowed …

Over 7.86 lakh people in India have been administered the COVID-19 vaccine, according to the health ministry. There have been four deaths among those vaccinated — three due to cardiac …

Hyderabad: Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine Covaxin, sources said on Tuesday. Out of those …

Vaccine-makers Bharat Biotech on Monday advised in a factsheet that people who are immuno-compromised or are taking medicines that affect their immune system should not take COVID-19 vaccine Covaxin. Bharat …

Bharat Biotech on Tuesday issued a set of cautionary guidelines for people with certain conditions who, it said, should consult with their vaccine provider and preferably avoid getting the Covaxin …

TipRanks These 3 “Strong Buy” Stocks Are Top Picks for 2021, Say Analysts Some traditions are too time-honored to shirk, and on Wall Street, the annual ‘top picks’ are one. …

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial …

 Bharat Biotech delivered 20,000 doses to Telangana state, sending the supplies to the state vaccine store at Koti here. Wednesday’s deliveries were made to Andhra Pradesh, Assam, Bihar, Delhi, Karnataka, …

Covaxin maker Bharat Biotech has signed an agreement with Precisa Medicamentos, a firm in Brazil, to supply the COVID-19 vaccine candidate to the Latin American country. The company will supply …

Hyderabad-headquartered Bharat Biotech flew the first batch of Covaxin, its two-dose Covid-19 vaccine, to 11 cities across India on Wednesday, a day after Serum Institute of India (SII) shipped batches …

The Union Health Ministry announced Tuesday all vaccine doses, 1.10 crore from Serum Insititute of India and 55 lakh from Bharat Biotech, will be given to all states and Union …

TipRanks Oppenheimer: These 3 Stocks Could Spike Over 80% Wall Street’s best firms don’t just look at the stocks, they look at the big picture, too. And Oppenheimer’s chief investment …

In his address at the inauguration of the 16th Pravasi Bharatiya Divas (PBD) Convention, Modi noted India’s image as the ‘world’s pharmacy’, and said it is ready with two locally …

Bharat Biotech International Limited, in a statement issued on Saturday with regard to reports of a volunteer’s demise during Phase III trials of its Covid-19 vaccine, cited cardio respiratory failure …

BBV154 (intranasal COVID-19 vaccine), preclinical testing has been completed for toxicology, immunogenicity and challenge studies. These studies have been conducted in the USA and India Representational image. ANI Buoyed by …

Covaxin has been developed by Hyderabad-based Bharat Biotech. (File photo) In a message posted on the company’s Twitter account, she thanked clinical trial sites, principal investigators and health workers for …

Serum Institute of India CEO Adar Poonawalla and Bharat Biotech managing director Dr Krishna Ella have in a joint statement Tuesday said that it was their combined intent to develop, …

The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India took place after the DCGI announced the approval of the Covaxin and Covishield vaccines Representational image. …